Fundraising Fox

Chimera Bioengineering

2 known investors

Find your way into Chimera Bioengineering

Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.

BiotechHealthtech

Investors · 2

Sand Hill AngelsMenlo Park · $50K – $2M
ShangBay Capital LLCPalo Alto

In the news

Fierce Biotech Layoff Tracker 2023: Reneo reduces workforce by 70%; Oxurion cuts staff down to 10fiercebiotech.com · Dec 2023Life Science Leader • May 2018 • Page 35qgdigitalpublishing.com · May 2018Kairos Ventures Invests in Chimera Bioengineeringkairosventures.com · Sep 2017Illumina Accelerator Introduces its Sixth Cycle of Genomic Startupsillumina.com · Jul 2017

Frequently asked questions

What does Chimera Bioengineering do?
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.
Who are Chimera Bioengineering's investors?
Chimera Bioengineering's investors include Sand Hill Angels, ShangBay Capital LLC.